Sulfur hexafluoride
Carotid Stenosis
Enrico AmmiratiSmall moleculePhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 47/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Carotid Stenosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CLOPIDOGREL Asan Medical Center | Phase 4 | BB |
ATORVASTATIN Columbia University | Phase 4 | BB |
EPHEDRINE, ANHYDROUS University Hospital, Clermont-Ferrand | Phase 4 | BB |
Acetylsalicylic Acid Asan Medical Center | Phase 4 | BB |
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril Asan Medical Center | Phase 4 | BB |
View all 25 →
Same molecule, other indications
Sulfur hexafluoride is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →